Erschienen in:
26.04.2018 | Maternal-Fetal Medicine
Fetal overgrowth in pregnancies complicated by diabetes: development of a clinical prediction index
verfasst von:
Tracy M. Tomlinson, Dorothea J. Mostello, Kee-Hak Lim, Jennifer S. Pritchard, Gil Gross
Erschienen in:
Archives of Gynecology and Obstetrics
|
Ausgabe 1/2018
Einloggen, um Zugang zu erhalten
Abstract
Purpose
To develop an index to predict fetal overgrowth in pregnancies complicated by diabetes.
Methods
Data were derived from a cohort of 275 women with singleton gestations in a collaborative diabetes in pregnancy program. Regression analysis incorporated clinical factors available in the first 20–30 weeks of pregnancy that were assigned beta-coefficient-based weights, the sum of which yielded a fetal overgrowth index (composite score).
Results
Fifty-one (18.5%) pregnancies were complicated by fetal overgrowth. The derived index included five clinical factors: age ≤ 30, history of macrosomia, excessive gestational weight gain, enlarged fetal abdominal circumference, and fasting hyperglycemia. Area under the curve (AUC) for the index is 0.88 [95% confidence interval (CI) 0.82–0.92]. Cut-points were selected to identify “high-risk” and “low-risk” ranges (≥ 8 and ≤ 3) that have positive and negative predictive values of 84% (95% CI 70–98%) and 95% (95% CI 92–98%), respectively. The majority of women in our cohort (n = 182, 66%) had a “low-risk” index while 9% (n = 25) had a “high-risk” index. Sub-analyses of nulliparous women and women with gestational and pre-gestational diabetes revealed that the overgrowth index was equally or more predictive when applied separately to each of these groups.
Conclusion
This fetal overgrowth index that incorporates five clinical factors provides a means of predicting fetal overgrowth and thereby serves as a tool for targeting the allocation of healthcare resources and treatment individualization.